National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

synthetic peptide-based erythropoiesis stimulating agent
A synthetic, non-recombinant, pegylated, peptidic erythropoiesis stimulating agent. Synthetic peptide-based erythropoiesis stimulating agent binds to and activates the erythropoietin (EPO) receptor on erythroid progenitor cells, thereby inducing their proliferation and differentiation into mature erythrocytes. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Hematide



Previous:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine, synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine, synthetic human corticotropin-releasing factor, synthetic human papillomavirus 16 E6 peptide, synthetic melanoma-associated antigens vaccine
Next:synthetic peptides E-PRA and E-PSM vaccine, Synthoestrin, Synthroid, T-Phyl, T138067 sodium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov